| Literature DB >> 15844828 |
Wei-Tien Chang1, Jenny Dao, Zuo-Hui Shao.
Abstract
Hawthorn (Crataegus) may play a role in the prevention and treatment of cardiovascular diseases such as hypertension, hyperlipidemia, and in particular, congestive heart failure. Evidence is accumulating that hawthorn may induce anti-ischemia/reperfusion-injury, anti-arrhythmic, hypolipidemic and hypotensive effects. These beneficial effects may in part be due to the presence of antioxidant flavonoid components. While a number of studies have been performed to evaluate the clinical efficacy of hawthorn, an international, multicenter, prospective clinical study including a large number of New York Heart Association (NYHA) class II/III heart failure patients is ongoing to test hawthorn's long-term therapeutic effects. Further clinical trials as well as pharmacokinetic and mechanistic studies are needed to explore and confirm its effectiveness, safety and pharmacological mechanism.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15844828 DOI: 10.1142/S0192415X05002606
Source DB: PubMed Journal: Am J Chin Med ISSN: 0192-415X Impact factor: 4.667